IDI (IDIP) Fair Value & Analysis
Financial Services · FR · Market cap €507M
Fair value as of: Jul 16, 2026
From 2 valuation models · updated 24 days ago
Fair value updated Jul 16, 2026, revised from €137.60 to €140.61 (+2.2%) since Jun 26, 2026.
A solid business, screening 97% undervalued on our models.
What matters now
- The price is below even our cautious bear case (€105.46). The market is more pessimistic than our downside scenario.
- Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality.
- For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range €32.02 – €76.26 · fair‑value band €105.46 – €175.76 · the €71.40 price screens below the €140.61 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.
Analysis
IDI (IDIP) currently trades at €71.40, while our model-based Fair Value estimate is €140.61, implying the stock looks roughly 96.9% undervalued today. The Quality Score stands at 60/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, IDI generated revenue of €81.0M at a net margin of 72.9%. Revenue declined 24.6% year over year. It earns a return on equity of 8.2%. The balance sheet holds a net cash position of €7.4M. Fundamentals as of Jul 16, 2026
Our scenario range runs from €105.46 (bear case) to €175.76 (bull case); at €71.40, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 7% below its 52-week high and 13% above its 52-week low, currently below its 200-day average. For context, the median of 10 Financial Services peers we cover trades at -12% fair-value upside, at 97%, IDIP screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: Multiples (€88.17) versus Asset-Based (€69.50). Highest evidence: P/B Multiple (55).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 59
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
IDI is a private equity firm specializing in leveraged buyouts, expansion capital, middle market, growth capital, acquisition of significant holdings in listed small and medium companies and secondary private equity portfolios, mezzanine financing, loans senior to senior debt, mergers and acquisitions, LBO, development capital, discounted leveraged buyouts …
Full company description
IDI is a private equity firm specializing in leveraged buyouts, expansion capital, middle market, growth capital, acquisition of significant holdings in listed small and medium companies and secondary private equity portfolios, mezzanine financing, loans senior to senior debt, mergers and acquisitions, LBO, development capital, discounted leveraged buyouts loans in mature companies and through co-investments in pre-IPO financing. Within fund of fund investments, the firm invests in private equity funds and Hedge funds. It seeks to invest in all sectors. It also prefers to invest in French and European SMEs/small cap and mid-cap companies. The firm primarily seeks to invest in France and European Developed Markets. The firm seeks to invest in 25 million ($26.81 million) and 60 million ($64.35 million) independently and up to 100+ million ($107.24 million) in co-investment. It generally makes an equity investment between 15 million ($16.28 million) and 150 million ($162.81 million). The firm prefers to invest between 25 million ($29.09 million) and 70 million ($81.47 million) in small and mid cap companies valued at between 10 million ($11.55 million) and 150 million ($174.58), and up to 250 million ($290.98 million) alongside co-investors. It invests in companies with an enterprise value ranging between 10 million ($11.55 million) and 300 million ($331.34 million) with the capacity to exceed this limit on a case-by-case basis and invests between 5 million ($5.52 million) and 25 million ($27.14 million) per deal. It seeks to invest in funds with a fund size between 50 million and 300 million ($331.34 million). The amount it invest in each transactions ranges from 25 million ($27.14 million) and 70 million ($82.54 million) and up to 100 million ($117.91 million) in case of joint investments. The firm takes majority and minority stakes in companies with a focus on majority positions in small and medium-sized companies acquiring through leveraged buyouts. The firm mainly invests through its own capital in both direct
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
IDI reported revenue of €20.2M in FY2025 versus €5.1M in FY2021, a compound +41.1%/yr. Reported net income was €59.0M in FY2025, compounding −17.3%/yr from FY2021.
Watch IDIP: get an alert when its fair value changes →
Peer Group
Asset Management · 973 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Asset Management median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $0.0420 | $0.0800 | +90% |
| BlackRock, Inc BLK | $1,136 | $465.75 | -59% |
| Blackstone Inc BX | $124.56 | $16.35 | -87% |
| Investor AB INVEB | kr 423.70 | kr 847.40 | +100% |
| Brookfield Corporation BN | C$62.45 | C$10.12 | -84% |
| KKR & Co KKR | $100.94 | $44.88 | -56% |
| AB Industrivärden INDUA | kr 532.50 | kr 1,065 | +100% |
| Jio Financial Services Limited JIOFIN | ₹242.98 | ₹40.19 | -83% |
| Hedef Holding HEDEF | 267.25 TRY | 320.98 TRY | +20% |
| Bajaj Holdings BAJAJHLDNG | ₹10,398 | ₹9,202 | -12% |
Compare IDI with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is IDI (IDIP) overvalued or undervalued?
What is the fair value of IDIP?
What is the quality score of IDIP?
What is the revenue of IDI (IDIP)?
What is the net profit margin of IDIP?
Does IDI pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track IDI and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.